Pemphigoid gestationis: A case report on maternal and neonatal outcomes.

IF 1.4 Q3 OBSTETRICS & GYNECOLOGY
International Journal of Reproductive Biomedicine Pub Date : 2026-09-28 eCollection Date: 2026-08-01 DOI:10.18502/ijrm.v24i8.21671
Azita Raeisi, Farkhondeh Farzamnia, Leila Bozorgian
{"title":"Pemphigoid gestationis: A case report on maternal and neonatal outcomes.","authors":"Azita Raeisi, Farkhondeh Farzamnia, Leila Bozorgian","doi":"10.18502/ijrm.v24i8.21671","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Pemphigoid gestationis is a rare skin disease of pregnancy. It can be misdiagnosed due to its many similarities to other dermatoses of pregnancy, and failure to diagnose can be associated with adverse maternal and fetal outcomes.</p><p><strong>Case presentation: </strong>We describe a 19-yr-old Iranian primiparous woman who admitted to the Imam Dermatology Clinic, Ahvaz, Iran, at 35 wk of gestation with extensive blistering lesions. Definite diagnosis was confirmed by skin biopsy, and systemic and topical therapies were initiated. The newborn was delivered by cesarean section at 38 wk of gestation due to ruptured membranes and meconium-stained amniotic fluid. The infant appeared healthy, with no skin manifestations. The disease flared after postpartum corticosteroid tapering, requiring re-escalation of therapy. At 6 wk postpartum, hyperpigmentation was fading without scarring, and pruritus was limited to new lesions.</p><p><strong>Conclusion: </strong>Timely diagnosis and multidisciplinary management of pemphigoid gestationis can prevent adverse maternal and fetal outcomes. The observed meconium passage at 38 wk warrants further investigation into potential fetal effects of this condition.</p>","PeriodicalId":14386,"journal":{"name":"International Journal of Reproductive Biomedicine","volume":"24 8","pages":"739-744"},"PeriodicalIF":1.4000,"publicationDate":"2026-09-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13655644/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Reproductive Biomedicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.18502/ijrm.v24i8.21671","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/8/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Pemphigoid gestationis is a rare skin disease of pregnancy. It can be misdiagnosed due to its many similarities to other dermatoses of pregnancy, and failure to diagnose can be associated with adverse maternal and fetal outcomes.

Case presentation: We describe a 19-yr-old Iranian primiparous woman who admitted to the Imam Dermatology Clinic, Ahvaz, Iran, at 35 wk of gestation with extensive blistering lesions. Definite diagnosis was confirmed by skin biopsy, and systemic and topical therapies were initiated. The newborn was delivered by cesarean section at 38 wk of gestation due to ruptured membranes and meconium-stained amniotic fluid. The infant appeared healthy, with no skin manifestations. The disease flared after postpartum corticosteroid tapering, requiring re-escalation of therapy. At 6 wk postpartum, hyperpigmentation was fading without scarring, and pruritus was limited to new lesions.

Conclusion: Timely diagnosis and multidisciplinary management of pemphigoid gestationis can prevent adverse maternal and fetal outcomes. The observed meconium passage at 38 wk warrants further investigation into potential fetal effects of this condition.

类天疱疮妊娠:一个病例报告的产妇和新生儿的结局。
背景:类天疱疮是一种罕见的妊娠皮肤病。由于它与其他妊娠皮肤病有许多相似之处,它可能被误诊,诊断失败可能与不良的母婴结局有关。病例介绍:我们描述了一名19岁的伊朗初产妇女,她在妊娠35周时被伊朗阿瓦士的伊玛目皮肤科诊所收治,伴有广泛的水泡病变。通过皮肤活检确诊,并开始全身和局部治疗。新生儿在妊娠38周时因羊膜破裂和羊水粪染色而剖宫产。婴儿看起来很健康,没有皮肤症状。产后皮质类固醇逐渐减少后,疾病突然发作,需要再次升级治疗。产后6周,色素沉着减退,无瘢痕,瘙痒仅限于新病灶。结论:类天疱疮妊娠的及时诊断和多学科管理可预防不良母婴结局。38周观察到的胎便通过值得进一步调查这种情况对胎儿的潜在影响。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
2.40
自引率
7.70%
发文量
93
审稿时长
16 weeks
期刊介绍: The International Journal of Reproductive BioMedicine (IJRM), formerly published as "Iranian Journal of Reproductive Medicine (ISSN: 1680-6433)", is an international monthly scientific journal for who treat and investigate problems of infertility and human reproductive disorders. This journal accepts Original Papers, Review Articles, Short Communications, Case Reports, Photo Clinics, and Letters to the Editor in the fields of fertility and infertility, ethical and social issues of assisted reproductive technologies, cellular and molecular biology of reproduction including the development of gametes and early embryos, assisted reproductive technologies in model system and in a clinical environment, reproductive endocrinology, andrology, epidemiology, pathology, genetics, oncology, surgery, psychology, and physiology. Emerging topics including cloning and stem cells are encouraged.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书